Cost of products sold, excluding amortization of intangible assets
Breakdown
| Segment | Q1 '26 |
|---|---|
| Cardiovascular | $1.16B |
| Medical Surgical | $867.00M |
| Neuroscience | $815.00M |
| Diabetes | $332.00M |
| Total | $3.26B |
| Segment | Q1 '26 |
|---|---|
| Cardiovascular | $1.16B |
| Medical Surgical | $867.00M |
| Neuroscience | $815.00M |
| Diabetes | $332.00M |
| Total | $3.26B |